drugset / Trial / NCT00032396

A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

NCT00032396

Treatment

Summary

A study evaluating Retisert in patients with age-related macular degeneration

Timeline

Start
2001-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject fluocinolone acetonide Small molecule

Indications